ClinicalTrials.gg
CompletedNCT07912554Updated Nov 3, 2026

Correcting Breastfeeding Myths, Knowledge, Self-efficacy and Practices

An interventional study of tele lactation and face to face in Breast Feeding, Primipara Women and the Study Focus on Health Education for Primipara, sponsored by Assiut University. Completed at 1 site in Egypt. Open to female participants. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Assiut University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Oct 2025, registered Oct 2026).
Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 14 studies in Breast Feeding with a site in Egypt — 4 open to participants now, 4 under way, none of them phase 3. Breast Feeding · Egypt.

Enrollment
5th of 12
132 · median 87
Started
2025
with 4 others
No phase
12 of 14
4 open now
Registered
14th of 14
by date
Lead sponsor
2 of 14
Assiut University

Among the 14 studies in Breast Feeding with a site in Egypt, this one is the 5th largest by enrollment of the 12 interventional ones, is one of 5 that started in 2025, is one of 12 with no phase, and was the 14th registered.

By phase

14 studies; the count open now beside each. This study's row is marked.

No phasethis study12 · 4 open
Observational2 · 0 open

By the year they started

First in 2003; this study’s year is marked. 5 started in 2025.

Size and results

Median enrollment 87 across the 12 interventional studies, 170 across the 2 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 14 studies in Breast Feeding with a site in Egypt, or all of them as a file.
02

Study summary

This study aims to evaluate and compare the effectiveness of a face-to-face intervention program and a tele-lactation intervention program on breastfeeding myths, knowledge, self-efficacy, and practices among primiparous mothers. Participants will be assigned to receive either face-to-face or tele-lactation guidance and support. Breastfeeding knowledge, self-efficacy, and practices will be assessed to determine the impact of each approach on improving outcomes for first-time mothers

03

Conditions studied

  • Breast Feeding
  • Primipara Women
  • the Study Focus on Health Education for Primipara
  • Breastfeeding

Browse trials for

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria

  • Primigravida women in the third trimester of pregnancy
  • Were at the end of the third trimester and expected to deliver during the study period
  • Were able to read and write.
  • Owned a smartphone
  • Had WhatsApp installed and were able to use it, particularly for participation in the tele-lactation intervention
  • Agreed to participate in the study and provided . Exclusion Criteria
  • Primiparous women were excluded if they had medical or obstetric conditions contraindicating
  • had serious maternal or fetal complications
  • inability to participate in the intervention or follow-up
  • declined to provide informed consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
132 participants (actual)

Study arms

  • Experimental
    tele lactation

    provide health education about breastfeeding to women via whatsapp

    Behavioral: tele lactation

  • Experimental
    face to face

    provide health education about breastfeeding to women via face to face

    Behavioral: face to face

  • No intervention
    control

    routine care

Interventions

  • Behavioraltele lactation

    provide health education about breastfeeding to women via whatsapp

  • Behavioralface to face

    provide health education about breastfeeding to women via face to face

06

What researchers measure

Primary outcomes

  1. breastfeeding knowledge

    The total knowledge score will be organized as follows: poor knowledge, if the total response score ˂ 50 %, neutral knowledge if the scores range from 50% to 75%, and good knowledge if the scores are\>75%

    Time frame: 2 months

  2. Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF)

    Assessed using the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), which consists of 14 items rated on a 3-point Likert scale (1 = not confident to 3 = confident). Total scores range from 14 to 42, with higher scores indicating better breastfeeding self-efficacy

    Time frame: 2 months

  3. primipara reported practices

    This tool consists of 28 items divided into four sections:preparation for breastfeeding (6 items), practices for latch on (7 items), practices during feeding (8 items), and post-feeding practices (7 items) Scoring system The total breastfeeding practice score ranged from 0 to 28. One point was awarded for each practiced item, and zero points were given for each item not practiced. A total score was calculated as a continuous variable and presented as the mean and standard deviation, with a higher mean score indicating a higher level of breastfeeding practice

    Time frame: 2 months

  4. Breastfeeding-related taboos and myths among Primiparous Women

    This 22-item tool assessed breastfeeding myths using factual and myth-based statements scored on a 2-point scale (1 = incorrect, 2 = correct), with reverse scoring applied to myths Total scores ranged from 22 to 44, where higher scores indicated better knowledge and fewer misconceptions

    Time frame: 2 months

07

Study locations

1 site
  • Faculty of Nursing
    Asyut, Egypt
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2025 to primary completion in Oct 2026, 12 months.

Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 12 months is close to that.

Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 27, 2026
First posted
Nov 3, 2026
StartActual
Oct 27, 2025
Primary completionActual
Oct 27, 2026
CompletionActual
Oct 27, 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07912554
Lead sponsor
Assiut University
Responsible party
Omyma Sayed Ali (assistant lecturer, Assiut University) — Principal investigator
First posted
Nov 3, 2026
Start date
Oct 27, 2025
Primary completion
Oct 27, 2026
Completion
Oct 27, 2026
Last update
Nov 3, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion